Children aged 6 months to 4 years in clinical risk groups to be offered COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that clinically vulnerable children aged 6 months to 4 years should be offered a Covid-19 vaccine.
NHS England has confirmed it will begin offering vaccinations to those eligible in England from mid-June 2023. Parents should wait to be contacted by NHS England before coming forward.
Eligible children in the below at-risk groups will be offered 2 doses of the vaccine, with an interval of 8 to 12 weeks between the first and second doses.
- a long-term lung condition, such as chronic obstructive pulmonary disease (COPD), asthma (if you need steroid tablets) or cystic fibrosis
- a long-term heart condition, such as congenital heart disease or chronic heart failure
- a long-term condition of the kidney, liver or digestive system
- a long-term problem with the brain or nerves, such as epilepsy, cerebral palsy, multiple sclerosis, an inherited condition or autism
- severe or multiple learning disabilities (or being on the learning disability register), such as Down’s syndrome
- diabetes or another hormone disorder, such as Addison’s disease
- a weakened immune system, due to a medical treatment (such as steroid medicine, biological therapy, chemotherapy or radiotherapy), a condition (such as leukaemia), a genetic condition or from having an organ or bone marrow transplant
- problems with the spleen, having no spleen or having a condition that can affect the spleen (such as sickle cell disease)
- a serious genetic condition that affects multiple systems in the body, such as mitochondrial disease
Information regarding this age group can be found here